Unknown

Dataset Information

0

Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2.


ABSTRACT: Both estrogen receptor (ER) and peroxisome proliferator-activated receptor gamma (PPARgamma) regulate bone metabolism, and because steroid receptor coactivator (SRC)-2 (TIF-2) enhances ER and PPARgamma activity, we examined the consequences of deletion of SRC-2 on bone using SRC-2 knock out (KO) mice. Loss of SRC-2 resulted in increased bone mass, with SRC-2 KO mice having 80% higher trabecular bone volume as compared with wild type mice. SRC-2 KO mice also had a marked decrease (by 50%) in bone marrow adipocytes. These data suggested that marrow precursor cells in the SRC-2 KO mice may be resistant to the inhibitory effects of endogenous PPARgamma ligands on bone formation. Consistent with this, compared with cultures from wild type mice, marrow stromal cultures from SRC-2 KO mice formed significantly more mineralized nodules (by 3-fold) in the presence of the PPARgamma agonist, rosiglitazone. Using chromatin immunoprecipitation analysis, we demonstrated that in bone marrow stromal cells, loss of SRC-2 leads to destabilization of the transcription complex at the peroxisome proliferator response elements of a number of PPARgamma target genes, resulting in an overall decrease in the expression of adipocyte-related genes and a marked decrease in adipocyte development. Using ovariectomy with or without estrogen replacement, we also demonstrated that SRC-2 KO mice were partially resistant to the skeletal actions of estrogen. Collectively, these findings indicate that loss of SRC-2 leads to partial skeletal resistance to the ER and PPARgamma, but resistance to PPARgamma is dominant, leading to increased bone mass. Modulating SRC-2 action may, thus, represent a novel therapeutic target for osteoporosis.

SUBMITTER: Modder UI 

PROVIDER: S-EPMC2707192 | biostudies-literature | 2009 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Skeletal consequences of deletion of steroid receptor coactivator-2/transcription intermediary factor-2.

Mödder Ulrike I UI   Monroe David G DG   Fraser Daniel G DG   Spelsberg Thomas C TC   Rosen Clifford J CJ   Géhin Martine M   Chambon Pierre P   O'Malley Bert W BW   Khosla Sundeep S  

The Journal of biological chemistry 20090507 28


Both estrogen receptor (ER) and peroxisome proliferator-activated receptor gamma (PPARgamma) regulate bone metabolism, and because steroid receptor coactivator (SRC)-2 (TIF-2) enhances ER and PPARgamma activity, we examined the consequences of deletion of SRC-2 on bone using SRC-2 knock out (KO) mice. Loss of SRC-2 resulted in increased bone mass, with SRC-2 KO mice having 80% higher trabecular bone volume as compared with wild type mice. SRC-2 KO mice also had a marked decrease (by 50%) in bone  ...[more]

Similar Datasets

| S-EPMC6645384 | biostudies-literature
| S-EPMC2582912 | biostudies-literature
| S-EPMC3367527 | biostudies-literature
| S-EPMC4076383 | biostudies-literature
| S-EPMC2921768 | biostudies-literature
| S-EPMC4280633 | biostudies-literature
| S-EPMC2998129 | biostudies-literature
| S-EPMC4036260 | biostudies-literature
| S-EPMC1478181 | biostudies-literature
| S-EPMC8715676 | biostudies-literature